SEARCH

SEARCH BY CITATION

References

  • 1
    Samuel D, Bismuth H. Liver transplantation for hepatitis B. Gastroenterol Clin North Am 1993; 22: 271283.
  • 2
    Lauchert W, Müller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 23872389.
  • 3
    Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, et al. Liver transplantation in Hbs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunisation. J Hepatol 1991; 13: 9096.
  • 4
    Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, et al. Passive immunoprophylaxis after liver transplantation in HBsAg positive patients. Lancet 1991; 337: 813815.
  • 5
    Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW. Fibros-ing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1990; 103: 13071312.
  • 6
    Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Sarzl TE. Or-thotopic liver transplantation for patients with hepatitis B virus—related liver disease. Hepatology 1991; 13: 619626.
  • 7
    Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, van Thiel DH. Incidence, prevalence, and clinical course of hepatitis B following liver transplantation. Gastroenterology 1992; 103: 323329.
  • 8
    Böker KH, Ringe B, Krüger M, Pichlmayr R, Manns MP. Prostaglandin E plus famciclovir—a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994; 57: 17061708.
  • 9
    Grellier L, Brown D, Berenek P, Rolles K, Burroughs A, Dusheiko G. Lamivudine prophylaxis: a new strategy for prevention of hepatitis B reinfection in liver transplantation for hepatitis B DNA positive cirrhosis. Single topic symposium on liver transplantation for chronic viral hepatitis, Reston, VA 1995.
  • 10
    Krüger M, Tillmann HL, Trautwein C, Oldhafer K, Böker KHW, Pichlmayr R, Manns MP. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation—a pilot study. Hepatology 1995; 22: 449.
  • 11
    Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, Bismuth H, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. Transplantation 1990; 49: 11551158.
  • 12
    Summers J, Measons WS. Replication of the genome of a hepatitis B-like virus by reverse transcription. Cell 1982; 29: 403415.
  • 13
    Pircher H, Moskophidis D, Rohrer U, Bürki K, Hengartner H, Zinkernagel RM. Viral escape by selection of cytotoxic T cell—resistant virus variants in vivo. Nature 1990; 346: 629633.
  • 14
    Lemon SM, Binn LN, Marchwicki R, Murphy PC, Ping LH, Jansen RW, Asher LV, et al. In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus. J Infect Dis 1990; 161: 713.
  • 15
    Howard CR, Brown SE, Hogben DN, Zuckerman AJ, Murray-Lyon IM, Steward MW. Analysis of antibody responses to hepatitis B surface antigen. Viral hepatitis and liver disease. Orlando, FL: Grune & Stratton 1984: 561572.
  • 16
    Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zucherman AJ, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325329.
  • 17
    Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis-B virus. J Hepatol 1991; 13: 105107.
  • 18
    Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992; 184: 11521157.
  • 19
    Okamoto H, Yano K, Nozaki Y, Matsui A, Miyaki H, Yamamoto K, Tsuda F, et al. Mutations within the s gene of hepatitis-B virus transmitted from mothers to babies immunized with hepatitis-B immune globulin and vaccine. Pediatr Res 1992; 32: 264268.
  • 20
    Waters J, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. Loss of the common ‘a’ determinant of hepatitis B surface antigen by a vaccine induced escape mutant. J Clin Invest 1992; 90: 25432547.
  • 21
    McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavi D, Tolpin MD, Nadler PI, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757766.
  • 22
    van Deursen, Carman WF. Envelope gene variation of Hepatitis B virus. J Mol Med 1996 (in press).
  • 23
    Tur-Kaspa R, Shaul Y, Moore DD, Burk BD, Okret S, Poellinger L, Shafritz DA. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988; 167: 630633.
  • 24
    Jiang JJ, Brind A, Gigon M, Samuel D, Feray C, Brechot C, Kremsdorf D. Evidence for the role of PBMC in the infection of liver graft and selection of hepatitis B variants after liver transplantation. Hepatology 1994; 20: 138A.
  • 25
    Borrego B, Norella IS, Giralt E, Andreu D, Domingo E. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol 1993; 67: 60716079.
  • 26
    Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker S, Böker D, Maschek H-J. Hepatitis B virus mutations in the press genome before and after liver transplantation. Hepatology 1996; 24: 482488.
  • 27
    Hawkins A, Gilson R, Gilbert N, Wreghiu T, Gray J, Boa IA-d, Tedder R, Alexander G. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996: 814.
  • 28
    Cariani E, Ravaggi A, Tanzi E, Romani L, Fiordalisi G, Bellati G, Caccamo L, Galmarini D, Albertini A, Zanetti A. Emergence of Hepatitis B virus S gene mutant in a liver transplant recipient. J Med Virol 1995; 47: 410415.